AI Article Synopsis

Article Abstract

Background: The palatal suture has been well known in literature as a method for palatal hemostasis but has not been validated for its efficacy. The aim of this parallel-arm randomized controlled clinical trial was to evaluate the efficacy of palatal pre-suturing using the greater palatine compression suture (GPCS) in reducing the perioperative hemorrhage associated with the palatal free gingival graft (FGG) procedure.

Methods: Twenty-four patients requiring the FGG procedure for recession coverage or augmentation of keratinized tissue were recruited in the study and randomized to the GPCS group and the control group. The GPCS was placed using a previously described protocol by a single operator in all the participants in the GPCS group. Perioperative blood loss was estimated by weighing the gauze used to mop the palatal hemorrhage, before and after the procedure. The time required for the surgery was also recorded by an independent observer.

Results: Significantly lesser blood loss was observed in the GPCS group (4.33 ± 0.89 g) as compared with the control group (8.91 ± 4.16 g). The difference in the time taken for the surgical procedure for the GPCS group (73.25 ± 22.35 minutes) was not significantly different from that required for the control group (76.08 ± 14.47 minutes).

Conclusion: This study demonstrates that pre-suturing of the palate using the GPCS is an effective technique to reduce the perioperative blood loss associated with the palatal FGG procedure.

Download full-text PDF

Source
http://dx.doi.org/10.1002/JPER.20-0754DOI Listing

Publication Analysis

Top Keywords

gpcs group
16
control group
12
blood loss
12
palatal pre-suturing
8
free gingival
8
gingival graft
8
randomized controlled
8
controlled clinical
8
clinical trial
8
associated palatal
8

Similar Publications

Article Synopsis
  • IBS and obesity can lead to alterations in the intestinal barrier, causing low-grade inflammation, which can be monitored using zonulin and intestinal fatty acid-binding protein (I-FABP) levels, along with urinary indican concentrations.
  • A 12-week Fitwalking program was tested on 57 mild IBS patients divided into obese, overweight, and normal weight groups, who walked three times a week, but no significant changes in most health metrics were found.
  • Despite limited changes in biochemical aspects, Fitwalking notably improved physical capacity in all groups and led to a decrease in inflammation levels, particularly in obese individuals, suggesting regular exercise may benefit gut health in this population.
View Article and Find Full Text PDF
Article Synopsis
  • - Tumorigenesis is often linked to Darwinian processes like natural selection, but advancing tumors also need the right group phenotypic composition (GPC) to thrive.
  • - The selective processes affecting tumor GPCs differ from classical natural selection because tumors aren't true evolutionary individuals and lack heritable fitness variation.
  • - The authors suggest that it's misleading to view tumorigenesis solely through a Darwinian lens; instead, understanding cancer progression requires recognizing that genetic and phenotypic diversity contributes to tumor success through a process known as "selection for function."
View Article and Find Full Text PDF

An effective method was developed for preparing galloylated procyanidins (GPCs) using galloyl-attached nucleophilic degradation. Under degradation conditions optimized through Box-Behnken design and single-factor experiments, two dimeric and three tetrameric GPCs were produced, with the yield of procyanidin B2-3'--gallate (B2-3'-G) reaching up to 232 mg/g (PPCs). The structure of B2-3'-G was identified by UV, FTIR, NMR, CD, MS, and phloroglucinolysis.

View Article and Find Full Text PDF

Irritable bowel syndrome (IBS) involves low-grade mucosal inflammation. Among the various approaches capable of managing the symptoms, physical activity is still under investigation. Despite its benefits, it promotes oxidative stress and inflammation.

View Article and Find Full Text PDF

Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis.

Cell Mol Neurobiol

March 2024

Stem Cell and Neurogenesis Group, School of Biomedical Sciences, Genomics Research Centre, Centre for Genomics and Personalised Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia.

Alzheimer's disease (AD) and traumatic brain injury (TBI) are major public health issues worldwide, with over 38 million people living with AD and approximately 48 million people (27-69 million) experiencing TBI annually. Neurodegenerative conditions are characterised by the accumulation of neurotoxic amyloid beta (Aβ) and microtubule-associated protein Tau (Tau) with current treatments focused on managing symptoms rather than addressing the underlying cause. Heparan sulfate proteoglycans (HSPGs) are a diverse family of macromolecules that interact with various proteins and ligands and promote neurogenesis, a process where new neural cells are formed from stem cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!